Антибиотики и Химиотерапия

LLC "Publishing House OKI"

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Антибиотики и Химиотерапия is an open-access journal published by LLC "Publishing House OKI" in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
LLC "Publishing House OKI"
ISSN
0235-2990
Country
Russia
Languages
russian
Access
Open access
Articles in DOAJ
1134
Declared review time
8 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2024-09-23
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

1134

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

797

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

9

i10-index

8

From OpenAlex open data (CC0).

Editorial & policy9
Last DOAJ review date
2024-09-24
Added to DOAJ
2024-09-23
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
99%
ORCID iDs in current deposits
90%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Antibiotics and chemoterapy
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Legal and Regulatory Analysis
  • Legal and Regulatory Analysis
  • Military Technology and Strategies
  • Military Technology and Strategies
  • Linguistic, Cultural, and Literary Studies
  • Linguistic, Cultural, and Literary Studies
  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
Show all subjects (50)
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Use and Resistance
  • Bacterial Identification and Susceptibility Testing
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Pneumonia and Respiratory Infections
  • Antibiotic Use and Resistance
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotics Pharmacokinetics and Efficacy
  • Influenza Virus Research Studies
  • Influenza Virus Research Studies
  • Antimicrobial Resistance in Staphylococcus
  • Antimicrobial Resistance in Staphylococcus
  • Bacterial biofilms and quorum sensing
  • Pediatric health and respiratory diseases
  • Bacterial biofilms and quorum sensing
  • Pediatric health and respiratory diseases
  • Bacteriophages and microbial interactions
  • Bacteriophages and microbial interactions
  • Microbial Natural Products and Biosynthesis
  • Microbial Natural Products and Biosynthesis
  • Long-Term Effects of COVID-19
  • Long-Term Effects of COVID-19
  • Pharmacological Effects of Natural Compounds
  • Neurological Disorders and Treatments
  • Pharmacological Effects of Natural Compounds
  • Neurological Disorders and Treatments
  • Human Health and Disease
  • Rheumatoid Arthritis Research and Therapies
  • Human Health and Disease
  • Bacillus and Francisella bacterial research
  • Clostridium difficile and Clostridium perfringens research
  • Clostridium difficile and Clostridium perfringens research
  • Rheumatoid Arthritis Research and Therapies
  • Bacillus and Francisella bacterial research
  • Seaweed-derived Bioactive Compounds
  • Fungal Biology and Applications

Keywords (DOAJ)

  • antibiotics
  • development of pharmaceuticals
  • chemotherapy
  • antibiotic resistance

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: